Can Hepatitis B Be Treated or Cured?

By Your Health Magazine Health Information Team

Can hepatitis B be treated? Yes. Acute hepatitis B usually resolves without antiviral medication, while chronic hepatitis B can often be controlled with antiviral treatment and regular monitoring. However, as of November 2026, available treatments do not reliably eliminate every trace of chronic hepatitis B virus from the body. Treatment can suppress the virus, protect the liver, and substantially reduce the risk of cirrhosis, liver failure, and liver cancer.

Acute and Chronic Hepatitis B Are Treated Differently

The first step is determining whether the infection is acute, meaning recently acquired, or chronic, meaning it has persisted for more than six months.

Type of infection	Typical treatment approach	Can it go away?
Acute hepatitis B	Supportive care, such as adequate fluids, nutrition, symptom management, and medical monitoring	Most healthy adults clear the infection through their immune response
Chronic hepatitis B	Ongoing monitoring and, when indicated, antiviral medication	Usually controlled rather than completely eradicated; some people achieve loss of hepatitis B surface antigen

There is no routine antiviral medicine for an uncomplicated acute infection. Severe cases may require hospitalization, particularly if there are signs of acute liver failure. The CDC’s hepatitis B treatment guidance explains that chronic infection is different: approved antiviral medicines are available, although not everyone with chronic hepatitis B needs medication immediately.

What Chronic Hepatitis B Treatment Can Accomplish

Chronic hepatitis B treatment is intended to reduce the amount of virus in the blood and limit ongoing liver inflammation. Successful treatment may:

Suppress hepatitis B virus DNA to very low or undetectable levels
Reduce liver inflammation and additional scarring
Lower the risk of cirrhosis, liver failure, and liver cancer
Help prevent transmission in certain circumstances, including during pregnancy
Improve long-term health and survival

Current professional guidance identifies entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide as preferred oral antiviral options for many patients. These medicines can suppress viral replication effectively, but treatment may need to continue for years or indefinitely. A person should never stop hepatitis B medication without guidance because viral activity and liver inflammation can rebound.

Pegylated interferon is another treatment option for selected patients. It is given for a limited period but is not appropriate for everyone and can cause significant side effects. Treatment selection depends on factors such as liver health, kidney function, pregnancy plans, other medical conditions, previous treatment, and the phase of the infection.

The AASLD and IDSA chronic hepatitis B guideline update describes the primary goals as viral suppression, prevention of liver complications, and, when possible, a functional cure through loss of hepatitis B surface antigen.

Is HBsAg Curable?

HBsAg stands for hepatitis B surface antigen. It is a protein associated with the virus and is one of the blood markers used to identify an active hepatitis B infection. HBsAg itself is not a separate disease, so asking whether HBsAg is curable generally means asking whether chronic hepatitis B can clear to the point that this marker disappears.

HBsAg loss is often called a functional cure. It means the surface antigen can no longer be detected, with or without the development of protective surface antibodies called anti-HBs. This is an excellent outcome and is associated with better long-term liver health, but it occurs in only a minority of treated patients.

A functional cure is not necessarily the same as completely removing all viral genetic material from every liver cell. Small amounts of hepatitis B material may remain, which is one reason the virus can sometimes reactivate during chemotherapy, organ transplantation, or treatment with immune-suppressing medicines. Anyone who currently has or previously had hepatitis B should inform their healthcare team before beginning such treatment.

How Doctors Decide Whether Treatment Is Needed

A positive HBsAg result alone does not determine whether medication should begin. A clinician—often a hepatologist, gastroenterologist, or infectious disease specialist—may consider:

HBV DNA, which measures how much virus is circulating
ALT and other liver enzyme results
HBeAg and anti-HBe blood markers
The amount of liver fibrosis or cirrhosis
Age, family history, and liver cancer risk
Pregnancy or plans for pregnancy
HIV, hepatitis C, or hepatitis D coinfection
Medicines or conditions that weaken the immune system

Testing may include bloodwork, ultrasound, and elastography, a noninvasive measurement of liver stiffness. Less commonly, a liver biopsy may be needed. The CDC hepatitis B screening recommendations support screening every adult at least once with HBsAg, anti-HBs, and total anti-HBc tests.

Some people have a low viral level, normal liver enzymes, and little evidence of liver damage. They may not need medication at that time, but they still need periodic monitoring because hepatitis B activity can change. “No medication right now” does not mean that follow-up is unnecessary.

Protecting Your Liver and Other People

Medical follow-up is only part of hepatitis B care. People with an infection should also:

Discuss alcohol use with their clinician because alcohol can add to liver damage. If testing is planned, review guidance on alcohol and liver function tests.
Check with a healthcare professional before using herbal products, supplements, or over-the-counter medicines that could affect the liver.
Ask about hepatitis A vaccination and testing for hepatitis C, hepatitis D, and HIV.
Maintain a healthy weight because fatty liver disease can create additional liver stress.
Keep scheduled blood tests, imaging appointments, and liver cancer surveillance when recommended.

Household members and sexual partners should be tested and vaccinated if they are not already immune. Do not share razors, toothbrushes, needles, or other objects that might contain blood. Cover open cuts and do not donate blood, organs, semen, or tissue. Hepatitis B is not spread by hugging, coughing, sharing meals, or ordinary social contact.

For a broader overview of conditions that can affect this organ, see the National Library of Medicine’s information on liver diseases and liver health.

When to Seek Care

Arrange an evaluation if you have a positive hepatitis B test, believe you were recently exposed, are pregnant and may have hepatitis B, or are about to receive chemotherapy or immune-suppressing treatment. Prompt assessment after a recent exposure is especially important because vaccination and, in some situations, hepatitis B immune globulin may help prevent infection when given quickly.

Seek urgent medical care for new or rapidly worsening jaundice, confusion, unusual sleepiness, repeated vomiting, severe abdominal swelling, vomiting blood, black or bloody stools, breathing difficulty, or an inability to keep fluids down. These symptoms can indicate serious liver disease or internal bleeding.

Hepatitis B is treatable even though chronic infection is not yet reliably eradicated by current therapy. With appropriate monitoring, antiviral treatment when needed, and steps to protect the liver, many people with hepatitis B can maintain good health for decades.